|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 496.07 USD | +2.49% |
|
+3.98% | +9.42% |
| 08-05 | Rothschild & Co Redburn Adjusts Vertex Pharmaceuticals Price Target to $580 From $570 | MT |
| 08-04 | Vertex Pharmaceuticals Seen Well Positioned Ahead of Pipeline Catalysts, UBS Says | MT |
Main competitors
| P/E (N) | Price to Book (N) | PEG (N) | EV / Sales (N) | EV / EBITDA (N) | EV / EBIT (N) | Dividend Yield (N) | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|
 | 29.24x | 5.49x | 2.72x | 8.46x | 19.14x | 19.99x | -.--% | 126B | |
| 33.6x | 20.62x | 0.63x | 12.29x | 24.81x | 26.32x | 0.58% | 1,057B | |
| 28.84x | - | -1.56x | - | - | - | 2.07% | 625B | |
| 32.34x | 366.15x | 0.15x | 7.35x | 15.3x | 15.93x | 2.81% | 435B | |
| 20.47x | 7.35x | 1.72x | 4.85x | 12.02x | 13.34x | 2.72% | 363B | |
| 22.14x | 6.24x | -9.65x | 5.72x | 14.28x | 15.13x | 2.8% | 296B | |
| 20.58x | 4.62x | 1.07x | 4.25x | 12.07x | 12.75x | 2.07% | 249B | |
| 25.76x | 18.01x | 2.13x | 6.79x | 12.06x | 15.59x | 2.45% | 222B | |
| 13.84x | 5.8x | -3.23x | 4.97x | 10.44x | 12.31x | 3.68% | 209B | |
| -41.38x | 8.23x | 0.28x | 5.93x | 33.46x | 57.99x | 2.47% | 165B | |
| 16.87x | 1.74x | 1.02x | 3.22x | 8.28x | 9.34x | 6.43% | 153B | |
| 11.53x | 5.43x | 0.19x | 3.23x | 8.46x | 9.08x | 3.91% | 132B | |
| 13.57x | 4.68x | 5.7x | 2.84x | 8.29x | 9.38x | 3.55% | 106B | |
| 11.97x | 1.22x | -7.07x | 2.14x | 6.9x | 7.68x | 5.65% | 104B | |
| 22.22x | 5.02x | 1.31x | 7.46x | 14.16x | 14.82x | 1.98% | 71.54B | |
| 21.15x | 1.75x | -0.13x | 1.71x | 8.09x | 13.58x | 0.32% | 56.57B | |
| 44.5x | 1.18x | 21.64x | 2.74x | 9.49x | 28.82x | 3.69% | 56.09B | |
| 39.23x | 5.23x | 2.18x | 8.89x | 29.53x | 30.89x | 0.48% | 53.41B | |
| 19.21x | 1.92x | 4.9x | 3.46x | 12.87x | 14.43x | 2.18% | 43.91B | |
| 47.44x | 4.75x | -1.24x | 3.2x | 11.79x | 13.33x | -.--% | 41.2B | |
| Average | 21.66x | 25.02x | 1.14x | 5.24x | 14.29x | 17.93x | 2.49% | 228.22B | |
| Weighted average by Cap. | 23.91x | 49.91x | -0.09x | 7.18x | 16.72x | 19.31x | 2.22% |
- Stock Market
- Stocks
- VRTX Stock
- Sector Vertex Pharmaceuticals Incorporated
- Sector valuations
Select your edition
All financial news and data tailored to specific country editions
